More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.34T
EPS
30.81
P/E ratio
39.5
Price to sales
13.93
Dividend yield
0.485%
Beta
0.398637
Previous close
$1,437.29
Today's open
$1,446.55
Day's range
$1,427.28 - $1,460
52 week range
$850.51 - $1,460
show more
CEO
Dave Ricks
Employees
50000
Headquarters
Indianapolis, IN
Exchange
New York Stock Exchange
Shares outstanding
940745031
Issue type
Common Stock
Healthcare
Pharmaceuticals
Mapping the Market: Eli Lilly shares ready to rally again
Shares in Eli Lilly rose more than 70% from their 2026 low to the record high they hit on Thursday, and more gains could be in store, technical analysis indicates.
Reuters • 17 hours ago

HIMS Partners With Lilly to Offer FDA-Approved Weight-Loss Drugs
Hims & Hers unites with Lilly to offer FDA-approved weight-loss drugs, Zepbound and Foundayo, expanding patient access and strengthening its obesity care platform.
Zacks Investment Research • 11 hours ago

4 Key Stocks to Watch Across Diabetes and Obesity This Awareness Day
LLY, NVO, VKTX and GPCR advance diabetes and obesity treatments, with promising drug candidates, expanding clinical studies and key pipeline milestones ahead.
Zacks Investment Research • 13 hours ago

China approves Eli Lilly's weight loss pill orforglipron
Eli Lilly on Thursday became the first drugmaker to have a GLP-1 weight-loss pill approved in China, giving it an edge over Danish rival Novo Nordisk (NOVOb.CO), opens new tab in the world's second-largest pharmaceutical market.
Reuters • Nov 12, 2026

Nvidia CEO Jensen Huang Says AI's 'Most Profound Impact' Will Be in Life Sciences -- and Eli Lilly Is Already Building on It
AI could improve the drug discovery and development process. Eli Lilly has made an important move to benefit from this.
The Motley Fool • Nov 12, 2026

More Good News for Eli Lilly Sends the Stock Even Higher
The medication also looks effective in reducing the severity of sleep apnea. Eli Lilly's share price rose on the news -- and there could be more in store.
The Motley Fool • Nov 12, 2026

The world's most sophisticated drug companies are putting billions into vaccines — despite the political environment
Look at the promising data for Moderna and Merck's experimental cancer vaccine and the research suggesting the shingles vaccine can delay dementia.
Market Watch • Nov 12, 2026

Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020
Facility will manufacture injectable medicines, including retatrutide Site will create 850 high-wage jobs and 2,000 construction jobs INDIANAPOLIS, Nov. 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today broke ground on a $3.5 billion manufacturing facility in Pennsylvania's Lehigh Valley. The site is one of 10 new U.S. manufacturing sites announced since 2020 and one of four among them dedicated to injectable medicines and devices.
PRNewsWire • Nov 12, 2026

Can LLY's Expanding Obesity Pipeline Sustain Its GLP-1 Leadership?
Lilly's expanding obesity pipeline, led by oral Foundayo and next-generation candidates retatrutide and EloraTZP, could strengthen its GLP-1 market leadership.
Zacks Investment Research • Nov 12, 2026

Nvidia CEO Out — 10 Stocks To Buy Before S&P 500 Hits 8,000
Nvidia (NVDA) is down over 30% from the highs with CEO Jensen Huang stepping down, yet Blanke Schein Wealth Management CIO Robert Schein says the stock is still a buy. He also names Broadcom (AVGO), Apple (AAPL), and Eli Lilly (LLY) among his top picks before the S&P 500 reaches 8,000.
The Street • Nov 12, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Eli Lilly and Company commission-free¹. Build wealth for the long term using automated trading and transfers.